Advertisement
Immunological control of ticks: Research towards development of an anti-tick vaccine for cattle
Upcoming SlideShare
Possible medications and vaccination for covid 19Possible medications and vaccination for covid 19
Loading in ... 3
1 of 1
Advertisement

More Related Content

Advertisement

More from ILRI(20)

Recently uploaded(20)

Advertisement

Immunological control of ticks: Research towards development of an anti-tick vaccine for cattle

  1. Immunological Control of Ticks: Research Towards Development of an Anti-Tick Vaccine for Cattle David Odongo1,6, Cassandra Olds1,5, Claudia Daubenberger2, Anthony Musoke3, Glen Scoles4, Don Knowles4, Richard Bishop1 1 International Livestock Research Institute, Nairobi; 2 Swiss Tropical and Public Health Institute; 3 Ondersterport Veterinary Institute, South Africa; 4 United States Department of Agriculture/Dept of Veterinary Microbiology and Pathology, Washington State University, USA; 5 Biosciences eastern and central Africa (BecA) Hub at ILRI, Nairobi; 6 University of Nairobi Ticks: How big a problem are they? Research Project objectives  Rhi pi cephal us (Boophi l us) appendi cul at us  To identify specific tick genes expressed in response to - The main tick vector of Theileria parva, the feeding and determine w hether these genes serve as anti- etiologic agent of East Coast fever (ECF), a tick or pathogen transmission blocking vaccine targets. lympho-proliferative killer disease of cattle Targeting internal vector/ parasite interface to identify genes that could serve as pathogen transmission blocking vaccine targets A cow suff eri ng f rom ECF. - Extreme anxiety due to possible loss of a lifetime investment - Death of young animals means Research Milestones – where are we? farmer cannot re-stock  R. appendiculatus salivary gland expressed sequence tags – underpins development of salivary gland protein based vaccine (mi mi cs natural i mmuni ty)  ECF i s endemi c i n 11 countri es i n A f ri ca. -A pprox 28 million cattle at risk, 1m deaths/ year  N ovel secreted proteins of R. appendiculatus salivary A nnual losses amount to US$300 million. gland isolated by functional screening  Tick cement cone protein (Trp64) show n to induce  Current control – intensive use of acaricides, how ever not cross-reactive response and protection against tick sustainable due to resistance, increasing costs and contamination infestation of livestock products and the environment  Immunization of cattle w ith a baculovirus expressed  Development of vaccine against tick infestation in cattle is a recombinant R. appendiculatus lipocalin fold resulted in promising field of research reduced number of adult female ticks feeding to engorgement and decreased egg production OUR RESEARCH GOAL  Tick/ pathogen combination construct vaccine developed and ready for testing in cattle  To contribute to sustainable integrated control of tick vectors of livestock disease by research related to development and deployment of vaccines against cattle ticks. This w ill reduce the utilization of environmentally- damaging acaricides for vector control. Expected outputs from on-going research Principle research questions we are asking:  Identify additional genes in tick gut and salivary glands for Immuno-modulatory proteins in tick salivary glands - can they use as antigens in subunit based vaccines serve as vaccine targets to prevent pathogen transmission? Bioinformatics and comparative genomics to identify tick gut A marketable tick vaccine genes that are up-regulated in response to tick feeding on host for the cattle industry? “ The TickGA RD experience” RN A interference – gene knockdow n to study biological function of identified candidate genes A vaccine that is effective, safe, affordable to the farmer, that is cost competitive and Does vaccination w ith recombinant antigen of protection w ill reduce intensive use of acaricides Concept of a combination vaccine rather than a “ silver bullet” Your Your institute/ institute/ partner partner logo logo
Advertisement